Accredited Investors’s MetLife MET Stock Holding History

Accredited Investors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,260	Closed	-$418K	–	123
2017 Q4	$418K	Sell	8,260 -900	-10%	-$47.4K	0.12%	71
2017 Q3	$476K	Buy	+9,160	New	+$446K	0.13%	66

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Accredited Investors's MET Position: Q1 2018 in Review

Accredited Investors sold out of MetLife (MET) in Q1 2018, closing a stake of 8,260 shares — an estimated $418K sold.

Accredited Investors first reported a position in MET in Q3 2017 and held it in 2 quarters. The position peaked at $476K in Q3 2017. 1,027 funds tracked by Wall St. Rank hold MET as of Q1 2018.

Accredited Investors reported no remaining MetLife position as of Q1 2018 after selling out during the quarter.
Accredited Investors sold 8,260 MetLife shares in Q1 2018, an estimated $418K.
Accredited Investors first reported a position in MetLife in Q3 2017 and held it in 2 quarters.
Accredited Investors's MetLife position peaked at $476K in Q3 2017.
1,027 funds tracked by Wall St. Rank held MetLife as of Q1 2018.

Based on Accredited Investors's 13F filing for Q1 2018, filed 18 Apr 2018.